Cracking novel shared targets between epilepsy and Alzheimer’s disease: need of the hour

References

Albani, D., Polito, L., Signorini, A., and Forloni, G. (2010). Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36, 370–376.Search in Google Scholar

Ali, I., Chugh, D., and Ekdahl, C.T. (2015). Role of fractalkine-CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain. Neurobiol. Dis. 74, 194–203.Search in Google Scholar

Alyu, F. and Dikmen, M. (2017). Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr. 29, 1–16.Search in Google Scholar

Amatniek, J.C., Hauser, W.A., DelCastillo-Castaneda, C., Jacobs, D.M., Marder, K., Bell, K., Albert, M., Brandt, J., and Stern, Y. (2006). Incidence and predictors of seizures in patients with Alzheimer’s disease. Epilepsia 47, 867–872.Search in Google Scholar

Andrzejczak, D. (2011). Epilepsy and pro-inflammatory cytokines. Immunomodulating properties of antiepileptic drugs. Neurol. Neurochir. Pol. 45, 275–285.Search in Google Scholar

Angelucci, F., De Bartolo, P., Gelfo, F., Foti, F., Cutuli, D., Bossu, P., Caltagirone, C., and Petrosini, L. (2009). Increased concentrations of nerve growth factor and brain-derived neurotrophic factor in the rat cerebellum after exposure to environmental enrichment. Cerebellum 8, 499–506.Search in Google Scholar

Anticevic, A., Cole, M.W., Murray, J.D., Corlett, P.R., Wang, X.J., and Krystal, J.H. (2012). The role of default network deactivation in cognition and disease. Trends Cogn. Sci. 16, 584–592.Search in Google Scholar

Armon, C., Peterson, G.W., and Liwnicz, B.H. (2000). Alzheimer’s disease underlies some cases of complex partial status epilepticus. J. Clin. Neurophysiol. 17, 511–518.Search in Google Scholar

Azab, S.F., Abdalhady, M.A., Almalky, M.A., Amin, E.K., Sarhan, D.T., Elhindawy, E.M., Allah, M.A., Elhewala, A.A., Salam, M.M., Hashem, M.I., et al. (2016). Serum and CSF adiponectin, leptin, and interleukin 6 levels as adipocytokines in Egyptian children with febrile seizures: a cross-sectional study. Ital. J. Pediatr. 42, 38–45.Search in Google Scholar

Bahna, S.G., Sathiyapalan, A., Foster, J.A., and Niles, L.P. (2014). Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer’s disease. Neurosci. Lett. 576, 84–87.Search in Google Scholar

Bakker, A., Krauss, G.L., Albert, M.S., Speck, C.L., Jones, L.R., Stark, C.E., Yassa, M.A., Bassett, S.S., Shelton, A.L., and Gallagher, M. (2012). Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74, 467–474.Search in Google Scholar

Bang, S.R., Ambavade, S.D., Jagdale, P.G., Adkar, P.P., Waghmare, A.B., and Ambavade, P.D. (2015). Lacosamide reduces HDAC levels in the brain and improves memory: potential for treatment of Alzheimer’s disease. Pharmacol. Biochem. Behav. 134, 65–69.Search in Google Scholar

Baranano, K.W. and Hartman, A.L. (2008). The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 10, 410–419.Search in Google Scholar

Barnham, K.J., Masters, C.L., and Bush, A.I. (2004). Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3, 205–214.Search in Google Scholar

Baviera, M., Roncaglioni, M.C., Tettamanti, M., Vannini, T., Fortino, I., Bortolotti, A., Merlino, L., and Beghi, E. (2017). Diabetes mellitus: a risk factor for seizures in the elderly – a population-based study. Acta Diabetol. doi:10.1007/s00592-017-1011-0. [Epub ahead of print].10.1007/s00592-017-1011-0Search in Google Scholar PubMed

Bell, R.D. and Zlokovic, B.V. (2009). Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease. Acta Neuropathol. 118, 103–113.Search in Google Scholar

Bender, A.C., Morse, R.P., Scott, R.C., Holmes, G.L., and Lenck-Santini, P.P. (2012). SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome. Epilepsy Behav. 23, 177–186.Search in Google Scholar

Bernardi, S., Scaldaferri, N., Vanacore, N., Trebbastoni, A., Francia, A., D’Amico, A., and Prencipe, M. (2010). Seizures in Alzheimer’s disease: a retrospective study of a cohort of outpatients. Epileptic Disord. 12, 16–21.Search in Google Scholar

Bhatti, A.B., Usman, M., Ali, F., and Satti, S.A. (2016). Vitamin supplementation as an adjuvant treatment for Alzheimer’s disease. J. Clin. Diagn. Res. 10, OE07–OE11.Search in Google Scholar

Bianchetti, A., Rozzini, R., and Trabucchi, M. (2003). Effects of acetyl-L-carnitine in Alzheimer’s disease patients unresponsive to acetylcholinesterase inhibitors. Curr. Med. Res. Opin. 19, 350–353.Search in Google Scholar

Boison, D. (2016). The biochemistry and epigenetics of epilepsy: focus on adenosine and glycine. Front. Mol. Neurosci. 9, 26–32.Search in Google Scholar

Boison, D. and Aronica, E. (2015). Comorbidities in neurology: is adenosine the common link? Neuropharmacology 97, 18–34.Search in Google Scholar

Bourinet, E., Soong, T.W., Sutton, K., Slaymaker, S., Mathews, E., Monteil, A., Zamponi, G.W., Nargeot, J., and Snutch, T.P. (1999). Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat. Neurosci. 2, 407–415.Search in Google Scholar

Braun, K.P. (2017). Preventing cognitive impairment in children with epilepsy. Curr. Opin. Neurol. 30, 140–147.Search in Google Scholar

Brigo, F., Igwe, S.C., and Del Felice, A. (2016). Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev. 11, CD006967.Search in Google Scholar

Brooks, C., Wei, Q., Cho, S.G., and Dong, Z. (2009). Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 119, 1275–1285.Search in Google Scholar

Cabrejo, L., Guyant-Marechal, L., Laquerriere, A., Vercelletto, M., De la Fourniere, F., Thomas-Anterion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., et al. (2006). Phenotype associated with APP duplication in five families. Brain 129, 2966–2976.Search in Google Scholar

Carter, D.S., Harrison, A.J., Falenski, K.W., Blair, R.E., and DeLorenzo, R.J. (2008). Long-term decrease in calbindin-D28K expression in the hippocampus of epileptic rats following pilocarpine-induced status epilepticus. Epilepsy Res. 79, 213–223.Search in Google Scholar

Chen, Y., Zhang, J., Zhang, B., and Gong, C.X. (2016). Targeting insulin signaling for the treatment of Alzheimer’s disease. Curr. Top. Med. Chem. 16, 485–492.Search in Google Scholar

Cheng, X.L. and Li, M.K. (2014). Effect of topiramate on apoptosis-related protein expression of hippocampus in model rats with Alzheimers disease. Eur. Rev. Med. Pharmacol. Sci. 18, 761–768.Search in Google Scholar

Cheng, T., Petraglia, A.L., Li, Z., Thiyagarajan, M., Zhong, Z., and Wu, Z. (2006). Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat. Med. 12, 1278–1285.Search in Google Scholar

Coppieters, N., Dieriks, B.V., Lill, C., Faull, R.L., Curtis, M.A., and Dragunow, M. (2014). Global changes in DNA methylation and hydroxymethylation in Alzheimer’s disease human brain. Neurobiol. Aging 35, 1334–1344.Search in Google Scholar

Deane, R., Du Yan, S., Submamaryan, R.K., LaRue, B., Jovanovic, S., and Hogg, E. (2003). RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 9, 907–913.Search in Google Scholar

Decressac, M., Wright, B., David, B., Tyers, P., Jaber, M., Barker, R.A., and Gaillard, A. (2011). Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 21, 233–238.Search in Google Scholar

Deepmala, Slattery. J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., and Frye, R. (2015). Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci. Biobehav. Rev. 55, 294–321.Search in Google Scholar

Demuro, A., Parker, I., and Stutzmann, G.E. (2010). Calcium signaling and amyloid toxicity in Alzheimer disease. J. Biol. Chem. 285, 12463–12648.Search in Google Scholar

Devi, L. and Ohno, M. (2013). Effects of levetiracetam, an antiepileptic drug, on memory impairments associated with aging and Alzheimer’s disease in mice. Neurobiol. Learn. Mem. 102, 7–11.Search in Google Scholar

DeVos, S.L., Goncharoff, D.K., Chen, G., Kebodeaux, C.S., Yamada, K., Stewart, F.R., Schuler, D.R., Maloney, S.E., Wozniak, D.F., Rigo, F., et al. (2013). Antisense reduction of tau in adult mice protects against seizures. J. Neurosci. 33, 12887–12897.Search in Google Scholar

Diaz, J.C., Simakova, O., Jacobson, K.A., Arispe, N., and Pollard, H.B. (2009). Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity. Proc. Natl. Acad. Sci. USA 106, 3348–3353.Search in Google Scholar

Doeser, A., Dickhof, G., Reitze, M., Uebachs, M., Schaub, C., Pires, N.M., Bonifacio, M.J., Soares-da-Silva, P., and Beck, H. (2015). Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug. Brain 138, 371–387.Search in Google Scholar

Dupuis, N., Matagne, A., Staelens, L., Dournaud, P., Desnous, B., Gressens, P., and Auvin, S. (2015). Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats. Epilepsia 56, 800–805.Search in Google Scholar

Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D.J., Ramesh, V., and Silva, A.J. (2008). Reversal of learning deficits in a TSC2^+/− mouse model of tuberous sclerosis. Nat. Med. 14, 843–838.Search in Google Scholar

Emilsson, L., Saetre, P., and Jazin, E. (2006). Alzheimer’s disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol. Dis. 21, 618–625.Search in Google Scholar

Feng, B., Tang, Y., and Chen, B. (2016). Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling. Sci. Rep. 6, 21931–21941.Search in Google Scholar

Friedman, D., Honig, L.S., and Scarmeas, N. (2012). Seizures and epilepsy in Alzheimer’s disease. CNS Neurosci. Ther. 18, 285–294.Search in Google Scholar

Ghasemi, M., Zendehbad, B., Zabihi, H., Hosseini, M., Hadjzadeh, M.A., and Hayatdavoudi, P. (2016). Beneficial effect of leptin on spatial learning and memory in streptozotocin-induced diabetic rats. Balkan Med. J. 33, 102–107.Search in Google Scholar

Go, M., Kou, J., Lim, J.E., Yang, J., and Fukuchi, K.I. (2016). Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer’s mouse model: implication of TLR4 signaling in disease progression. Biochem. Biophys. Res. Commun. 479, 331–337.Search in Google Scholar

Gomez Ravetti, M.G., Rosso, O.A., Berretta, R., and Moscato, P. (2010). Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus’ gene expression profiles in Alzheimer’s disease. PLoS One 5, e10153-94.Search in Google Scholar

Goodison, W.V., Vincenza, F., and Kehoe, P.G. (2012). Calcium channel blockers and Alzheimer’s disease: potential relevance in treatment strategies of metabolic syndrome. J. Alz. Dis. 30, S269–S282.Search in Google Scholar

Gueli, M.C. and Taibi, G. (2013). Alzheimer’s disease: amino acid levels and brain metabolic status. Neurol. Sci. 34, 1575–1579.Search in Google Scholar

Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., and Majounie, E. (2013). Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer’s disease. N. Engl. J. Med. 368, 117–127.Search in Google Scholar

Hamid, H., Ettinger, A.B., and Mula, M. (2011). Anxiety symptoms in epilepsy: salient issues for future research. Epilepsy Behav. 22, 63–68.Search in Google Scholar

Harte-Hargrove, L., MacLusky, N.J., and Scharfman, H.E. (2013). BDNF-estrogen interactions in hippocampal mossy fiber pathway: implications for normal brain function and disease. Neuroscience 239, 46–66.Search in Google Scholar

Haussmann, R., Mayer, T., Schrempf, W., and Donix, M. (2017). Alzheimer’s disease and epilepsy. Nervenarzt. 88, 1003–1009.Search in Google Scholar

Hebert, S.S., Horre, K., Nicolai, L., Papadopoulou, A.S., Mandemakers, W., Silahtaroglu, A.N., Kauppinen, S., Delacourte, A., and De Strooper, B. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. USA 105, 6415–6420.Search in Google Scholar

Henshall, D.C. and Kobow, K. (2015). Epigenetics and epilepsy. Cold Spring Harb. Perspect. Med. 5, 1–17.Search in Google Scholar

Hollingworth, P., Harold, D., Sims, R., Gerrish, A., Lambert, J.C., Carrasquillo, M.M., Abraham, R., Hamshere, M.L., Pahwa, J.S., Moskvina, V., et al. Alzheimer’s Disease Neuroimaging Initiative, CHARGE Consortium, and EADI1 Consortium. (2011). Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat. Genet. 43, 429–435.Search in Google Scholar

Hu, X., Zhou, X., He, W., Yang, J., Xiong, W., Wong, P., Wilson, C.G., and Yan, R. (2010). BACE1 deficiency causes altered neuronal activity and neurodegeneration. J. Neurosci. 30, 8819–8829.Search in Google Scholar

Huang, W.J., Tian, F.F., Chen, J.M., Guo, T.H., Ma, Y.F., Fang, J., Dang, J., and Song, M.Y. (2013). GSK-3β may be involved in hippocampal mossy fiber sprouting in the pentylenetetrazole-kindling model. Mol. Med. Rep. 8, 1337–1342.Search in Google Scholar

Ickes, B.R., Pham, T.M., Sanders, L.A., Albeck, D.S., Mohammed, A.H, and Granholm, A.C. (2000). Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp. Neurol. 164, 45–52.Search in Google Scholar

Iori, V., Iyer, A.M., Ravizza, T., Beltrame, L., Paracchini, L., Marchini, S., Cerovic, M., Hill, C., Ferrari, M., Zucchetti, M., et al. (2017). Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy. Neurobiol. Dis. 99, 12–23.Search in Google Scholar

Iqbal, K., Liu, F., Gong, C.X., Alonso, A.D.C., and Grundke-Iqbal, I. (2009). Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 118, 53–69.Search in Google Scholar

Islam, B.U. and Tabrez, S. (2017). Management of Alzheimer’s disease – an insight of the enzymatic and other novel potential targets. Int. J. Biol. Macromol. 97, 700–709.Search in Google Scholar

Ittner, L.M. and Gotz, J. (2010). Amyloid-band tau – a toxic pas de deux in Alzheimer’s disease. Nat. Rev. Neurosci. 12, 65–72.Search in Google Scholar

Jayadev, S., Leverenz, J.B., Steinbart, E., Stahl, J., Klunk, W., Yu, C, and Bird, T.D. (2010). Alzheimer’s disease phenotypes and genotypes associated with mutations in presenilin 2. Brain 133, 1143–1154.Search in Google Scholar

Jones, N.C., Nguyen, T., Corcoran, N.M., Velakoulis, D., Chen, T., Grundy, R., O’Brien, T.J., and Hovens, C.M. (2012). Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. Neurobiol. Dis. 45, 897–901.Search in Google Scholar

Kanner, A.M. (2009). Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 15, 83–87.Search in Google Scholar

Kharatmal, S.B., Singh, J.N., and Sharma, S.S. (2015). Rufinamide improves functional and behavioral deficits via blockade of tetrodotoxin-resistant sodium channels in diabetic neuropathy. Curr. Neurovasc. Res. 12, 262–268.Search in Google Scholar

Kim, D.Y., Carey, B.W., Wang, H., Ingano, L.A., Binshtok, A.M., Wertz, M.H., Pettingell, W.H., He, P., Lee, V.M., Woolf, C.J., et al. (2007). BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat. Cell Biol. 9, 755–764.Search in Google Scholar

Kim, Y., Wilkins, K.M., and Tampi, R.R. (2008). Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence. Drugs Aging 25, 187–196.Search in Google Scholar

Kobayashi, D., Zeller, M., Cole, T., Buttini, M., McConlogue, L., Sinha, S., Freedman, S., Morris, R.G., and Chen, K.S. (2008). BACE1 gene deletion: impact on behavioral function in a model of Alzheimer’s disease. Neurobiol. Aging 29, 861–873.Search in Google Scholar

Kohli, M.A., John-Williams, K., Rajbhandary, R., Naj, A., Whitehead, P., and Hamilton, K. (2013). Repeat expansions in the C9ORF72 gene contribute to Alzheimer disease in Caucasians. Neurobiol. Aging 34, 1519.e5–1519.e12.Search in Google Scholar

Korotkov, A.G., Muzalevskaya, D.S., and Kolokolov, O.V. (2016). A role of antioxidants in the complex treatment of epilepsy. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 116, 44–48.Search in Google Scholar

Kramer, T., Schmidt, B., and Lo Monte, F. (2012). Small-molecule inhibitors of GSK-3: structural insights and their application to Alzheimer’s disease models. Int. J. Alzheimer’s Dis. 2012, 1–32.Search in Google Scholar

Kumar, H., Katyal, J., and Gupta, Y.K. (2015). Low dose zinc supplementation beneficially affects seizure development in experimental seizure models in rats. Biol. Trace Elem. Res. 163, 208–216.Search in Google Scholar

Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., et al. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458.Search in Google Scholar

Larner, A.J. (2010). Epileptic seizures in AD patients. Neuromol. Med. 12, 71–77.Search in Google Scholar

Larner, A.J. (2011). Presenilin-1 mutation Alzheimer’s disease: a genetic epilepsy syndrome? Epilepsy Behav. 21, 20–22.Search in Google Scholar

Lazarczyk, M.J., Hof Patrick, R., Constantin, B., and Panteleimon, G. (2012). Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med. 10, 127–139.Search in Google Scholar

Lee, C.Y., Jaw, T., Tseng, H.C., Chen, I.C., and Liou, H.H. (2012). Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus. PLoS One 7, e38789.Search in Google Scholar

Leppik, I.E. and Birnbaum, A.K. (2010). Epilepsy in the elderly. Ann. N.Y. Acad. Sci. 1184, 208–224.Search in Google Scholar

Letra, L., Santana, I., and Seiça, R. (2014). Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines. Metab. Brain Dis. 29, 563–568.Search in Google Scholar

Levin, E.D., Bushnell, P.J., and Rezvani, A.H. (2011). Attention-modulating effects of cognitive enhancers. Pharmacol. Biochem. Behav. 99, 146–154.Search in Google Scholar

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.E., Jondro, P.D., Schmidt, S.D., Wang, K., et al. (1995). Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 269, 973–977.Search in Google Scholar

Levy, N., Milikovsky, D.Z., Baranauskas, G., Vinogradov, E., David, Y., Ketzef, M., Abutbul, S., Weissberg, I., Kamintsky, L., Fleidervish, I., et al. (2015). Differential TGF-β signaling in glial subsets underlies IL-6-mediated epileptogenesis in mice. J. Immunol. 195, 1713–1722.Search in Google Scholar

Lewerenz, J. and Maher, P. (2015). Chronic glutamate toxicity in neurodegenerative diseases – what is the evidence? Front. Neurosci. 9, 469–488.Search in Google Scholar

Lewis, M.H. (2004). Environmental complexity and central nervous system development and function. Ment. Retard. Dev. Disabil. Res. Rev. 10, 91–95.Search in Google Scholar

Li, L., Zhang, S., Zhang, X., Li, T., Tang, Y., Liu, H., Yang, W., and Le, W. (2013). Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer’s disease. Curr. Alzheimer Res. 10, 433–441.Search in Google Scholar

Li, Y., Sun, H., Chen, Z., Xu, H., Bu, G., and Zheng, H. (2016). Implications of GABAergic neurotransmission in Alzheimer’s disease. Front. Aging Neurosci. 8, 31–42.Search in Google Scholar

Lichtenthaler, S.F. (2012). Alpha-secretase cleavage of the amyloid precursor protein: proteolysis regulated by signaling pathways and protein trafficking. Curr. Alzheimer Res. 9, 165–177.Search in Google Scholar

Liu, Y.J. and Chern, Y. (2015). AMPK-mediated regulation of neuronal metabolism and function in brain diseases. J. Neurogenet. 29, 50–58.Search in Google Scholar

Liu, S.J., Zheng, P., Wright, D.K., Dezsi, G., Braine, E., Nguyen, T., Corcoran, N.M., Johnston, L.A., Hovens, C.M., Mayo, J.N., et al. (2016). Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau. Brain 139, 1919–1938.Search in Google Scholar

Liu, C., Russin, J., Heck, C., Kawata, K., Adiga, R., Yen, W., Lambert, J., Stear, B., Law, M., Marquez, Y., et al. (2017). Dysregulation of PINCH signaling in mesial temporal epilepsy. J. Clin. Neurosci. 36, 43–52.Search in Google Scholar

Loef, M., von Stillfried, N., and Walach, H. (2012). Zinc diet and Alzheimer’s disease: a systematic review. Nutr. Neurosci. 15, 2–12.Search in Google Scholar

Long, Z., Zheng, M., Zhao, L., Xie, P., Song, C., Chu, Y., Song, W., and He, G. (2013). Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer’s disease mice model. Curr. Alzheimer Res. 10, 261–269.Search in Google Scholar

Long, Z.M., Zhao, L., Jiang, R., Wang, K.J., Luo, S.F., Zheng, M., Li, X.F., and He, G.Q. (2015). Valproic acid modifies synaptic structure and accelerates neurite outgrowth via the glycogen synthase kinase-3β signaling pathway in an Alzheimer’s disease model. CNS Neurosci. Ther. 21, 887–897.Search in Google Scholar

Lu, H., Liu, X., Deng, Y., and Qing, H. (2013). DNA methylation, a hand behind neurodegenerative diseases. Front. Aging Neurosci. 5, 85–100.Search in Google Scholar

Lyketsos, C.G., Carrillo, M.C., Ryan, J.M., Khachaturian, A.S., Trzepacz, P., Amatniek, J., Cedarbaum, J., Brashear, R., and Miller, D.S. (2011). Neuropsychiatric symptoms in Alzheimer’s disease. Alzheimers Dement. 7, 532–539.Search in Google Scholar

Marsh, J., Bagol, S.H., Williams, R.S.B., Dickson, G., and Alifragis, P. (2017). Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acid. Neurobiol. Dis. 106, 63–75.Search in Google Scholar

Martinc, B., Grabnar, I., and Vovk, T. (2012). The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress. Curr. Neuropharmacol. 10, 328–343.Search in Google Scholar

Masuda, N., Peng, Q., Li, Q., Jiang, M., Liang, Y., Wang, X., Zhao, M., Wang, W., Ross, C.A., and Duan, W. (2008). Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington’s disease. Neurobiol. Dis. 30, 293–302.Search in Google Scholar

Mathew, J., Paul, J., Nandhu, M.S, and Paulose, C.S. (2010). Bacopa monnieri and Bacoside-A for ameliorating epilepsy associated behavioral deficits. Fitoterapia 81, 315–322.Search in Google Scholar

Mazhar, F., Malhi, S.M., and Simjee, S.U. (2017). Comparative studies on the effects of clinically used anticonvulsants on the oxidative stress biomarkers in pentylenetetrazole-induced kindling model of epileptogenesis in mice. J. Basic Clin. Physiol. Pharmacol. 28, 31–42.Search in Google Scholar

McCagh, J., Fisk, J.E., and Baker, G.A. (2009). Epilepsy, psychosocial and cognitive functioning. Epilepsy Res. 86, 1–14.Search in Google Scholar

McGuire, M.J. and Ishii, M. (2016). Leptin dysfunction and Alzheimer’s disease: evidence from cellular, animal, and human studies. Cell. Mol. Neurobiol. 36, 203–217.Search in Google Scholar

Menendez, M. (2005). Down syndrome, Alzheimer’s disease and seizures. Brain Dev. 27, 246–252.Search in Google Scholar

Michalak, Z., Lebrun, A., Di Miceli, M., Rousset, M.C., Crespel, A., Coubes, P., Henshall, D.C., Lerner-Natoli, M., and Rigau, V. (2012). IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood-brain barrier disruption. J. Neuropathol. Exp. Neurol. 71, 826–838.Search in Google Scholar

Millan, M.J., Agid, Y., Brune, M., Bullmore, E.T., Carter, C.S., Clayton, N.S., Connor, R., and Davis, S. (2012). Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat. Rev. Drug Discov. 11, 141–168.Search in Google Scholar

Miller-Delaney, S.F., Bryan, K., Das, S., McKiernan, R.C., Bray, I.M., Reynolds, J.P., Gwinn, R., Stallings, R.L., and Henshall, D.C. (2015). Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain 138, 616–631.Search in Google Scholar

Minkeviciene, R., Rheims, S., Dobszay, M.B., Zilberter, M., Hartikainen, J., Fulop, L., Penke, B., Zilberter, Y., Harkany, T., Pitkanen, A., et al. (2009). Amyloid β-induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 29, 3453–3462.Search in Google Scholar

Moncek, F., Duncko, R., Johansson, B.B., and Jezova, D. (2004). Effect of environment on stress related systems in rats. J. Neuroendocrinol. 16, 423–431.Search in Google Scholar

Nagahara, A.H., Merrill, D.A., Coppola, G., Tsukada, S., Schroeder, B.E., Shaked, G.M., Wang, L., Blesch, A., Kim, A., Conner, J.M., et al. (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat. Med. 15, 331–317.Search in Google Scholar

Nalivaeva, N.N., Belyaev, N.D., Lewis, D.I., Pickles, A.R., Makova, N.Z., Bagrova, D.I., Dubrovskaya, N.M., Plesneva, S.A., Zhuravin, I.A., and Turner, A.J. (2012). Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J. Mol. Neurosci. 46, 569–577.Search in Google Scholar

Noebels, J. (2011). A perfect storm: converging paths of epilepsy and Alzheimer’s dementia intersect in the hippocampal formation. Epilepsia 52 (Suppl. 1), 39–46.Search in Google Scholar

Nygaard, H.B., Kaufman, A.C., Sekine-Konno, T., Huh, L.L., Going, H., Feldman, S.J., Kostylev, M.A., and Strittmatter, S.M. (2015). Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model. Alzheimers Res. Ther. 7, 25–36.Search in Google Scholar

Okada, T., Wada, J., Hida, K., Eguchi, J., Hashimoto, I., Baba, M., Yasuhara, A., Shikata, K., and Makino, H. (2006). Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Diabetes. 55, 1666–1677.Search in Google Scholar

Olin, J.T., Fox, L.S., Pawluczyk, S., Taggart, N.A., and Schneider, L.S. (2001). A pilot randomize trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease. Am. J. Geriatr. Psychiatry. 9, 400–405.Search in Google Scholar

Ono, K., Takasaki, J., Takahashi, R., Ikeda, T., and Yamada, M. (2013). Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro. J. Neurosci. Res. 91, 1371–1381.Search in Google Scholar

Ortiz, R.M., Karkkainen, I., Huovila, A.P., and Honkaniemi, J. (2005). ADAM9, ADAM10, and ADAM15 mRNA levels in the rat brain after kainic acid-induced status epilepticus. Brain Res. Mol. Brain Res. 137, 272–275.Search in Google Scholar

Ozdemir, A.Y., Rom, I., Kovalevich, J., Yen, W., Adiga, R., Dave, R.S., and Langford, D. (2013). PINCH in the cellular stress response to tau-hyperphosphorylation. PloS One 8, e58232.Search in Google Scholar

Palmio, J., Vuolteenaho, K., Lehtimaki, K., Nieminen, R., Peltola, J., and Moilanen, E. (2016). CSF and plasma adipokines after tonic-clonic seizures. Seizure 39, 10–12.Search in Google Scholar

Palop, J.J., Chin, J., Roberson, E.D., Wang, J., Thwin, M.T., Bien-Ly, N., Yoo, J., Ho, K., Yu, G.Q., Kreitzer, A., et al. (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55, 697–711.Search in Google Scholar

Paul, V., Reddy, L., Ekambaram, P. (2005). A reversal by L-arginine and sodium nitro-prusside of ageing-induced memory impairment in rats by increasing nitric oxide concentration in the hippocampus. Indian J. Physiol. Pharmacol. 49, 179–186.Search in Google Scholar

Paul, V. and Ekambaram, P. (2011). Involvement of nitric oxide in learning & memory processes. Indian J. Med. Res. 133, 471–478.Search in Google Scholar

Perluigi, M., Di Domenico, F., and Butterfield, D.A. (2015). mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy. Neurobiol. Dis. 84, 39–49.Search in Google Scholar

Pitsikas, N., Rigamonti, A.E., Cella, S.G., and Sakellaridis, N. (2005). The nitric oxide donor molsidomine antagonizes age-related memory deficit in rats. Neurobiol. Aging 26, 259–264.Search in Google Scholar

Ramos-Miguel, A., Hercher, C., Beasley, C.L., Barr, A.M., Bayer, T.A., Falkai, P., Leurgans, S.E., Schneider, J.A., Bennett, D.A., and Honer, W.G. (2015). Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol. Neurodegener. 10, 65–82.Search in Google Scholar

Randall, A.D., Witton, J., Booth, C., Hynes-Allen, A., and Brown, J.T. (2010). The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 59, 243–267.Search in Google Scholar

Rao, S.C., Dove, G., Cascino, G.D., and Petersen, R.C. (2009). Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome. Epilepsy Behav. 14, 118–120.Search in Google Scholar

Roane, D.M., Feinberg, T.E., Meckler, L., Miner, C.R., Scicutella, A., and Rosenthal, R.N. (2000). Treatment of dementia-associated agitation with gabapentin. J. Neuropsychiatry Clin. Neurosci. 12, 40–43.Search in Google Scholar

Roberson, E.D., Halabisky, B., Yoo, J.W., Yao, J., Chin, J., Yan, F., Wu, T., Hamto, P., Devidze, N., Yu, G.Q., et al. (2011). Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease. J. Neurosci. 31, 700–711.Search in Google Scholar

Roseti, C., Fucile, S., Lauro, C., Martinello, K., Bertollini, C., and Esposito, V. (2013). Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy. Epilepsia 54, 1834–1844.Search in Google Scholar

Russo, E., Donato di Paola E., Gareri, P., Siniscalchi, A., Labate, A., Gallelli, L., Citraro, R., and De Sarro, G. (2013). Pharmacodynamic potentiation of antiepileptic drugs’ effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol. Res. 70, 1–12.Search in Google Scholar

Sada, N., Lee, S., Katsu, T., Otsuki, T., and Inoue, T. (2015). Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science 347, 1362–1367.Search in Google Scholar

San, Y.Z., Liu, Y., Zhang, Y., Shi, P.P., and Zhu, Y.L. (2015). Peroxisome proliferator-activated receptor-γ agonist inhibits the mammalian target of rapamycin signaling pathway and has a protective effect in a rat model of status epilepticus. Mol. Med. Rep. 12, 1877–1883.Search in Google Scholar

Sanchez, P.E., Zhu, L., Verret, L., Vossel, K.A., Orr, A.G., Cirrito, J.R., Devidze, N., Ho, K., Yu, G.Q., Palop, J.J., et al. (2012). Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model. Proc. Natl. Acad. Sci. USA 109, E2895–E2903.Search in Google Scholar

Scharfman, H.E. (2012). Alzheimer’s disease and epilepsy: insight from animal models. Future Neurol. 7, 177–192.Search in Google Scholar

Scharfman, H.E. and Chao, M.V. (2012). The entorhinal cortex in Alzheimer’s disease. Eur. J. Neurodegener. Dis. 1, 53–66.Search in Google Scholar

Scharfman, H.E. and MacLusky, N.J. (2008). Estrogen-growth factor interactions and their contributions to neurological disorders. Headache 48 (Suppl. 2), S77–S89.Search in Google Scholar

Scichilone, J.M., Yarraguntla, K., Charalambides, A., Harney, J.P., and Butler, D. (2016). Environmental enrichment mitigates detrimental cognitive effects of ketogenic diet in weanling rats. J. Mol. Neurosci. 60, 1–9.Search in Google Scholar

Shi, J.Q., Wang, B.R., Tian, Y.Y., Xu, J., Gao, L., Zhao, S.L., Jiang, T., Xie, H.G., and Zhang, Y.D. (2013). Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice. CNS Neurosci. Ther. 19, 871–881.Search in Google Scholar

Shultz, S.R., Wright, D.K., Zheng, P., Stuchbery, R., Liu, S.J., Sashindranath, M., Medcalf, R.L., Johnston, L.A., Hovens, C.M., Jones, N.C., et al. (2015). Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury. Brain 138, 1297–1313.Search in Google Scholar

Simeone, T.A., Matthews, S.A., Samson, K.K., and Simeone, K.A. (2017). Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy. Exp. Neurol. 287, 54–64.Search in Google Scholar

Song, J., Hur, B.E., Bokara, K.K., Yang, W., Cho, H.J., Park, K.A., Lee, W.T., Lee, K.M., and Lee, J.E. (2014). Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. Yonsei Med. J. 55, 689–699.Search in Google Scholar

Sontag, J.M., Nunbhakdi-Craig, V., Montgomery, L., Arning, E., Bottiglieri, T., and Sontag, E. (2008). Folate deficiency induces in vitro and mouse brain region-specific downregulation of Leucine carboxyl methyltransferase-1 and protein phosphatase 2A Bα subunit expression that correlate with enhanced tau phosphorylation. J. Neurosci. Nurs. 28, 11477–11487.Search in Google Scholar

Sperk, G., Bellmann, R., Gruber, B., Greber, S., Marksteiner, J., Röder, C., and Rupp, E. (1996). Neuropeptide Y expression in animal models of temporal lobe epilepsy. Epilepsy Res. (Suppl.) 12, 197–203.Search in Google Scholar

Spilman, P., Podlutskaya, N., Hart, M.J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., and Galvan, V. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer’s disease. PLoS One 5, e9979-86.Search in Google Scholar

Stark, A.K., Pelvig, D.P., Jorgensen, A.M., Andersen, B.B., and Pakkenberg, B. (2005). Measuring morphological and cellular changes in Alzheimer’s dementia: a review emphasizing stereology. Curr. Alzheimer Res. 2, 449–481.Search in Google Scholar

Suter, M.R., Kirschmann, G., Laedermann, C.J., Abriel, H., and Decosterd, I. (2013). Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state. Anesthesiology. 118, 160–172.Search in Google Scholar

Tan, Y., Deng, Y., and Qing, H. (2012). Calcium channel blockers and Alzheimer’s disease. Neural Regen. Res. 15, 137–140.Search in Google Scholar

Thebault-Dagher, F., Herba, C.M., Seguin, J.R., Muckle, G., Lupien, S.J., Carmant, L., Simard, M.N., Shapiro, G.D., Fraser, W.D., and Lippe, S. (2017). Age at first febrile seizure correlates with perinatal maternal emotional symptoms. Epilepsy Res. 135, 95–101.Search in Google Scholar

Thom, M., Liu, J.Y., Thompson, P., Phadke, R., Narkiewicz, M., Martinian, L., Marsdon, D., Koepp, M., Caboclo, L., Catarino, C.B., et al. (2011). Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study. Brain 134, 2969–2981.Search in Google Scholar

Thundyil, J., Pavlovski, D., Sobey, C.G., and Arumugam, T.V. (2012). Adiponectin receptor signalling in the brain. Br. J. Pharmacol. 165, 313–327.Search in Google Scholar

Tiwari, S.K., Seth, B., Agarwal, S., Yadav, A., Karmakar, M., Gupta, S.K., Choubey, V., Sharma, A., and Chaturvedi, R.K. (2015). Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an amyloid-β toxin-induced Alzheimer rat model via the phosphatidylinositol 3-kinase (PI3K)/Akt/Wnt/β-catenin pathway. J. Biol. Chem. 290, 28540–28558.Search in Google Scholar

Tracy, T.E. and Gan, L. (2017). Acetylated tau in Alzheimer’s disease: an instigator of synaptic dysfunction underlying memory loss: increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy. Bioessays 39, 1–9.Search in Google Scholar

Tremolizzo, L., Messina, P., Conti, E., Sala, G., Cecchi, M., Airoldi, L., Pastorelli, R., Pupillo, E., Bandettini Di Poggio, M., Filosto, M., et al. (2014). Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of Age of onset. Amyotroph. Lateral Scler. Frontotemporal Degener. 15, 98–105.Search in Google Scholar

Turrigiano, G.G. (2011). Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu. Rev. Neurosci. 34, 89–103.Search in Google Scholar

Vassar, R. (2014). BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease. Alzheimers Res. Ther. 24, 89–104.Search in Google Scholar

Verret, L., Mann, E.O., Hang, G.B., Barth, A.M., Cobos, I., Ho, K., Devidze, N., Masliah, E., Kreitzer, A.C., Mody, I., et al. (2012). Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708–721.Search in Google Scholar

Vezzani, A., French, J., Bartfai, T., and Baram, T.Z. (2011). The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31–40.Search in Google Scholar

Vossel, K.A., Tartaglia, M.C., Nygaard, H.B., Zeman, A.Z., and Miller, B.L. (2017). Epileptic activity in Alzheimer’s disease: causes and clinical relevance. Lancet Neurol. 16, 311–322.Search in Google Scholar

Wang, J., Liu, Y., Li, X.H., Zeng, X.C., Li, J., Zhou, J., Xiao, B., and Hu, K. (2017). Curcumin protects neuronal cells against status-epilepticus-induced hippocampal damage through induction of autophagy and inhibition of necroptosis. Can. J. Physiol. Pharmacol. 95, 501–509.Search in Google Scholar

Warner, T.A., Kang, J.Q., Kennard, J.A., and Harrison, F.E. (2015). Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer’s disease. Epilepsy Res. 110, 20–25.Search in Google Scholar

Wong, S.B., Cheng, S.J., Hung, W.C., Lee, W.T., and Min, M.Y. (2015). Rosiglitazone suppresses in vitro seizures in hippocampal slice by inhibiting presynaptic glutamate release in a model of temporal lobe epilepsy. PLoS One 10, 1–14.Search in Google Scholar

Wu, H., Lu, M.H., Wang, W., Zhang, M.Y., Zhu, Q.Q., Xia, Y.Y., Xu, R.X., Yang, Y., Chen, L.H., and Ma, Q.H. (2015). Lamotrigine reduces β-site AβPP-cleaving enzyme 1 protein levels through induction of autophagy. J Alzheimers Dis. 46, 863–876.Search in Google Scholar

Xia, P., Chen, H.S., Zhang, D., and Lipton, S.A. (2010). Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J. Neurosci. 30, 11246–11250.Search in Google Scholar

Xu, X., Russel, T., Bazner, J., and Hamilton, J. (2001). NMDA receptor antagonist AP5 and nitric oxide synthase inhibitor 7-NI affect different phase of learning and memory in gold fish. Brain Res. 889, 274–277.Search in Google Scholar

Xu, R., Thomas, E.A., Gazina, E.V., Richards, K.L., Quick, M., and Wallace, R.H. (2007). Generalized epilepsy with febrile seizures plus-associated sodium channel β1 subunit mutations severely reduce β subunit-mediated modulation of sodium channel function. Neuroscience 148, 164–174.Search in Google Scholar

Xu, Y., Chen, Y., Zhang, P., Jeffrey, PIA.D., and Shi, Y. (2008a). Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated tau dephosphorylation. Mol. Cell 31, 873–885.Search in Google Scholar

Xu, L., Rensing, N., Yang, X.F., Zhang, H.X., Thio, L.L., Rothman, S.M., Weisenfeld, A.E., Wong, M., and Yamada, K.A. (2008b). Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. J. Clin. Invest. 118, 272–280.Search in Google Scholar

Xu, Y., Zeng, K., Han, Y., Wang, L., Chen, D., Xi, Z., Wang, H., Wang, X., and Chen, G. (2012). Altered expression of CX3CL1 in patients with epilepsy and in a rat model. Am. J. Pathol. 180, 1950–1962.Search in Google Scholar

Xuan, A.G., Pan, X.B., Wei, P., Ji, W.D., Zhang, W.J., Liu, J.H., Hong, L.P., Chen, W.L., and Long, D.H. (2015). Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer’s disease. Mol. Neurobiol. 51, 300–312.Search in Google Scholar

Yang, Y., Hu, W., Jiang, S., Wang, B., Li, Y., Fan, C., Di, S., Ma, Z., Lau, W.B., and Qu, Y. (2015). The emerging role of adiponectin in cerebrovascular and neurodegenerative diseases. Biochim. Biophys. Acta 1852, 1887–1894.Search in Google Scholar

Yao, Z.G., Liang, L., Liu, Y., Zhang, L., Zhu, H., Huang, L., and Qin, C. (2014). Valproate improves memory deficits in an Alzheimer’s disease mouse model: investigation of possible mechanisms of action. Cell. Mol. Neurobiol. 34, 805–812.Search in Google Scholar

Yildiz Akar, E., Ulak, G., Tanyer, P., Erden, P., Utkan, T., and Gacar, N. (2007). 7-nitroindazole, a neuronal nitric oxide synthase inhibitor impairs passive-avoidance and elevated plus-maze memory performance in rats. Pharmacol. Biochem. Behav. 87, 434–443.Search in Google Scholar

Zeng, L., Xu, L., Gutmann, D.H., and Wong, M. (2008). Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann. Neurol. 63, 444–453.Search in Google Scholar

Zhang, Y.W., Thompson, R., Zhang, H., and Xu, H. (2011). APP processing in Alzheimer’s disease. Mol. Brain 4, 3–15.Search in Google Scholar

Zhang, M.Y., Zheng, C.Y., Zou, M.M., Zhu, J.W., Zhang, Y., Wang, J., Liu, C.F., Li, Q.F., Xiao, Z.C., Li, S., et al. (2014). Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice. Neurobiol. Aging 35, 2713–2725.Search in Google Scholar

Zimmerman, G., Njunting, M., Ivens, S., Tolner, E.A., Behrens, C.J, and Gross, M. (2008). Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats. Eur. J. Neurosci. 27, 965–975.Search in Google Scholar

Ziyatdinova, S., Gurevicius, K., Kutchiashvili, N., Bolkvadze, T., Nissinen, J., Tanila, H., and Pitkanen, A. (2011). Spontaneous epileptiform discharges in a mouse model of Alzheimer’s disease are suppressed by antiepileptic drugs that block sodium channels. Epilepsy Res. 94, 75–85.Search in Google Scholar

Zufferey, V., Donati, A., Popp, J., Meuli, R., Rossier, J., Frackowiak, R., Draganski, B., von Gunten, A., and Kherif, F. (2017). Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer’s disease. Alzheimers Dement. 7, 107–114.Search in Google Scholar